Joo Hyun Lim1, Jung Kim2, Sang Gyun Kim3, Hyunsoo Chung2. 1. Department of Internal Medicine, Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, South Korea. 2. Division of Gastroenterology, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Daehangno 101, Jongno-gu, 03080, Seoul, South Korea. 3. Division of Gastroenterology, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Daehangno 101, Jongno-gu, 03080, Seoul, South Korea. harley1333@hanmail.net.
Abstract
BACKGROUND: The efficacy of endoscopic submucosal dissection (ESD) for undifferentiated early gastric cancer (UD EGC) is controversial due to the relatively high risk of lymph node metastasis. We compared long-term clinical outcomes of UD EGC between ESD and surgical resection groups. METHODS: We retrospectively reviewed the medical records of patients with UD EGC treated by either ESD or surgical resection between January 2007 and December 2014. Long-term clinical outcomes were compared between the two groups in terms of survival. RESULTS: A total of 1147 patients were enrolled with median follow-up duration of 59.1 months. ESD and surgical resections were performed in 126 and 1021 patients respectively. Additional surgery was performed in 22 patients after ESD. There were no significant differences in overall survival [total, p = 0.641; propensity score matching (PSM), p = 0.330; expanded criteria, p = 0.512]. Although the disease-free survival rate was lower in ESD group because of the higher rate of metachronous cancer development (total, p < 0.001; PSM, p = 0.001), the difference was not significant in the group within expanded criteria (p = 0.071). CONCLUSIONS: ESD could be a comparable treatment option with surgical resection for UD EGC within expanded criteria in terms of long-term survival. It is mandatory to establish a meticulous indication of ESD for UD EGC considering the risk of lymph node metastasis.
BACKGROUND: The efficacy of endoscopic submucosal dissection (ESD) for undifferentiated early gastric cancer (UD EGC) is controversial due to the relatively high risk of lymph node metastasis. We compared long-term clinical outcomes of UD EGC between ESD and surgical resection groups. METHODS: We retrospectively reviewed the medical records of patients with UD EGC treated by either ESD or surgical resection between January 2007 and December 2014. Long-term clinical outcomes were compared between the two groups in terms of survival. RESULTS: A total of 1147 patients were enrolled with median follow-up duration of 59.1 months. ESD and surgical resections were performed in 126 and 1021 patients respectively. Additional surgery was performed in 22 patients after ESD. There were no significant differences in overall survival [total, p = 0.641; propensity score matching (PSM), p = 0.330; expanded criteria, p = 0.512]. Although the disease-free survival rate was lower in ESD group because of the higher rate of metachronous cancer development (total, p < 0.001; PSM, p = 0.001), the difference was not significant in the group within expanded criteria (p = 0.071). CONCLUSIONS: ESD could be a comparable treatment option with surgical resection for UD EGC within expanded criteria in terms of long-term survival. It is mandatory to establish a meticulous indication of ESD for UD EGC considering the risk of lymph node metastasis.
Entities:
Keywords:
Early gastric cancer; Endoscopic submucosal dissection; Survival rate; Undifferentiated
Authors: Min Woo Chung; Oh Jeong; Young Kyu Park; Kyung Hwa Lee; Jae Hyuk Lee; Wan Sik Lee; Young Eun Joo; Sung Kyu Choi; Sung Bum Cho Journal: Korean J Gastroenterol Date: 2014-02
Authors: Chen Li; Sungsoo Kim; Ji Fu Lai; Sung Jin Oh; Woo Jin Hyung; Won Hyuk Choi; Seung Ho Choi; Zheng Gang Zhu; Sung Hoon Noh Journal: Ann Surg Oncol Date: 2007-11-28 Impact factor: 5.344
Authors: H Isomoto; S Shikuwa; N Yamaguchi; E Fukuda; K Ikeda; H Nishiyama; K Ohnita; Y Mizuta; J Shiozawa; S Kohno Journal: Gut Date: 2008-11-10 Impact factor: 23.059
Authors: Alexandre Moraes Bestetti; Diogo Turiani Hourneaux de Moura; Igor Mendonça Proença; Epifanio Silvino do Monte Junior; Igor Braga Ribeiro; João Guilherme Ribeiro Jordão Sasso; Angelo So Taa Kum; Sergio A Sánchez-Luna; Wanderley Marques Bernardo; Eduardo Guimarães Hourneaux de Moura Journal: Front Oncol Date: 2022-07-12 Impact factor: 5.738